Have never been more excited about CYDY. Hoping for a LH trial large enough to gather much data. Have long felt that many indications (CFS,COPD, Lupus,etc...) are misdiagnosed. If I understand, LL's MOA negates the need for specific diagnosis.
That being what it is, what do you think should qualify someone for the trial?
Imho, regardless of indication, LL is going to make a lot of people feel & perform much better. Placebo effect should be mute, as that will be shared.
I feel that even a large trial would enroll very quickly, if not too picky. If CYDY gets too specific, the "moving target" might come into play.
At this point, I like the opportunity to gather much data for multiple indications more than rolling the dice on just one. And the safety record just grows.
s/c is quite different, imho.
Your thoughts? Sorry, if this has already been discussed- then pay me no mind or mention.